Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001359164 | SCV001555026 | benign | Adams-Oliver syndrome 5 | 2023-11-24 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV002261354 | SCV002541044 | uncertain significance | not provided | 2021-11-17 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001359164 | SCV002553454 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002271227 | SCV002553455 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003150425 | SCV003837917 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2022-03-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003150425 | SCV005027182 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2023-11-15 | criteria provided, single submitter | clinical testing | The p.N1327S variant (also known as c.3980A>G), located in coding exon 24 of the NOTCH1 gene, results from an A to G substitution at nucleotide position 3980. The asparagine at codon 1327 is replaced by serine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |